HK1134788A1 - Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health - Google Patents

Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health

Info

Publication number
HK1134788A1
HK1134788A1 HK10102997.7A HK10102997A HK1134788A1 HK 1134788 A1 HK1134788 A1 HK 1134788A1 HK 10102997 A HK10102997 A HK 10102997A HK 1134788 A1 HK1134788 A1 HK 1134788A1
Authority
HK
Hong Kong
Prior art keywords
preventing
periodontal
drug target
oral health
novel drug
Prior art date
Application number
HK10102997.7A
Other languages
English (en)
Inventor
Tor Ny
Jinan Li
Yongzhi Guo
Tomas Lindh
Original Assignee
Jinan Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Li filed Critical Jinan Li
Publication of HK1134788A1 publication Critical patent/HK1134788A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/484Plasmin (3.4.21.7)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK10102997.7A 2006-08-28 2010-03-23 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health HK1134788A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82366506P 2006-08-28 2006-08-28
US94411107P 2007-06-15 2007-06-15
PCT/SE2007/050586 WO2008027000A2 (en) 2006-08-28 2007-08-28 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health

Publications (1)

Publication Number Publication Date
HK1134788A1 true HK1134788A1 (en) 2010-05-14

Family

ID=39136398

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10102997.7A HK1134788A1 (en) 2006-08-28 2010-03-23 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health

Country Status (9)

Country Link
US (3) US20100028321A1 (xx)
EP (1) EP2056865B1 (xx)
JP (1) JP5566106B2 (xx)
AU (1) AU2007290882B2 (xx)
CA (1) CA2662083C (xx)
DK (1) DK2056865T3 (xx)
ES (1) ES2453496T3 (xx)
HK (1) HK1134788A1 (xx)
WO (1) WO2008027000A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101517626B1 (ko) 2006-08-28 2015-05-07 옴니오 헤아레르 에이비 감염에 대항하는 후보물질
US20130164228A1 (en) * 2011-12-21 2013-06-27 Colgate-Palmolive Company Compositions comprising gallates and gallamides
US9723558B2 (en) 2012-04-27 2017-08-01 Qualcomm Incorporated Method and apparatus for signaling in dense network operations
CN104721621A (zh) * 2015-03-24 2015-06-24 孟勇 一种治疗种植体周围炎的药物组合物及其应用
JP2018524067A (ja) 2015-06-11 2018-08-30 アットウィル メディカル ソルーションズ インコーポレイテッド アンチトロンビン−ヘパリン組成物を利用する医療機器、システムおよび方法
TWI801331B (zh) * 2015-11-03 2023-05-11 美商波麥堤克生物治療股份有限公司 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法
TWI624268B (zh) 2015-12-18 2018-05-21 Talengen Institute Of Life Sciences Co Ltd 纖溶酶原在製備藥劑上的用途及包括纖溶酶原之藥劑
CN108463235A (zh) * 2015-12-18 2018-08-28 泰伦基国际有限公司 一种用于预防和治疗宫颈糜烂的方法
TWI746581B (zh) * 2016-12-15 2021-11-21 大陸商深圳瑞健生命科學硏究院有限公司 纖溶酶原在製備預防和治療脂質腎損傷之藥劑上的用途
CA3047175A1 (en) * 2016-12-15 2018-06-21 Talengen International Limited Method for mitigating heart disease
TW201822812A (zh) 2016-12-15 2018-07-01 深圳瑞健生命科學硏究院有限公司 一種預防和治療肥胖症的方法
CN110114079A (zh) 2016-12-15 2019-08-09 泰伦基国际有限公司 一种预防和治疗肥胖症的方法和药物
TW201904990A (zh) 2017-06-23 2019-02-01 美商波麥堤克生物治療股份有限公司 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療
WO2021155867A1 (zh) * 2020-02-06 2021-08-12 泰伦基国际有限公司 一种预防和治疗多发性硬化症的方法和药物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023143A (en) 1959-10-14 1962-02-27 American Cyanamid Co Process for preparing a veterinary composition
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
US5397578A (en) 1994-03-29 1995-03-14 Tovarischestvo S Ogranichennoi Otvetstvennostiju "Taurus" Method of treatment of chronic purulent inflammations of ear in children
US6420622B1 (en) 1997-08-01 2002-07-16 3M Innovative Properties Company Medical article having fluid control film
WO2000004941A1 (en) 1998-07-24 2000-02-03 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US6656496B1 (en) * 1999-03-01 2003-12-02 The Uab Research Foundation Porous tissue scaffolding materials and uses thereof
US20030026794A1 (en) * 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
HUP0600436A3 (en) * 2001-11-26 2010-12-28 Genentech Inc Catheter composition and uses thereof
WO2003066842A2 (de) 2002-02-06 2003-08-14 Trommsdorff Gmbh & Co. Kg Arzneimittel Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen
CN1420126A (zh) 2002-07-10 2003-05-28 牛勃 一种重组人纤溶酶原Kringle5突变体蛋白rhPK-5的制备方法
KR101517626B1 (ko) 2006-08-28 2015-05-07 옴니오 헤아레르 에이비 감염에 대항하는 후보물질

Also Published As

Publication number Publication date
EP2056865B1 (en) 2013-12-25
US20100028321A1 (en) 2010-02-04
CA2662083C (en) 2016-09-20
US10086052B2 (en) 2018-10-02
DK2056865T3 (en) 2014-03-24
EP2056865A4 (en) 2012-01-25
JP2010502601A (ja) 2010-01-28
WO2008027000A2 (en) 2008-03-06
AU2007290882B2 (en) 2013-02-21
EP2056865A2 (en) 2009-05-13
WO2008027000A3 (en) 2008-05-22
US20180360931A1 (en) 2018-12-20
JP5566106B2 (ja) 2014-08-06
CA2662083A1 (en) 2008-03-06
US20160184411A1 (en) 2016-06-30
AU2007290882A1 (en) 2008-03-06
ES2453496T3 (es) 2014-04-08

Similar Documents

Publication Publication Date Title
HK1134788A1 (en) Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
ZA200801511B (en) Novel diazaspiroalkanes and their use for treatment of CCR8 medicated diseases
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
EP2510916A4 (en) ANTISEPTIC PHARMACEUTICAL COMPOSITION USEFUL FOR ORAL HYGIENE AND THE TREATMENT OF BUCCAL DISEASES OF MICROBIAL ORIGIN
IL211120A (en) Compound, tetracycline converted at position 7c with fluorine, a pharmaceutical preparation containing it and its use in the preparation of drugs for the treatment of bacteria-caused infection
EP1804787A4 (en) FLAVONOID COMPOSITION FOR THE TREATMENT OF BUCCO-DENTAL DISEASES
DE602005014145D1 (de) Medikamente zur behandlung oder prävention fibrotischer krankheiten
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL218277B (en) Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
DE502005003840D1 (de) Anlage zur nichtinvasiven medizinischen behandlung
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
GB2435425B (en) Medical wound healing treatment
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
EP2098240A4 (en) MEDIUM TO PROMOTE THE HEALING OF A LIVING BODY
GB0603630D0 (en) Medical wound healing treatment
EP1773882A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH SIGLEC-6
IL198704A0 (en) Therapeutic compositions and vaccines for treating a tumor or infection
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
EP2231148A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE